4-ethyl-2-mercapto-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydroquinoline-3-carbonitrile, 95.0%, 1g

N-Carbamoyl L-Glutamic Acid>95.0%(T)1g

4-Chloro-2-(trifluoromethyl)pyrido[2,3-d]pyrimidine, 97%, 100mg

tert-Butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95.0%, 1g

N-?[(11bS)?-?2,?6-?Bis[3,?5-?bis(trifluoromethyl)?phenyl]?-?4-?oxido-dinaphtho[2,?1-?d:1',?2'-?f]?[1,?3,?2]?dioxaphosphepin-?4-?yl]?-?1,?1,?1-?trifluoromethanesulfonamide, 97%, 50mg

6-(Benzyloxy)-2,3-dihydro-1H-inden-1-one, 97%, 2g

Z-NMe-L-norleucine, 1g

Hemalum solution acid acc. to Mayer, 500 ml, glass

(2S,3S)-2-Methyl-3-((methylsulfonyl)methyl)azetidine hydrochloride, 98%, 5g

Ethyl 2-(3-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetate, 95.0%, 1g

tert-Butyl (3-(methylamino)cyclobutyl)carbamate, 97%, 500mg

Dibenzofuran-4-boronic acid, 98.0%, 100g

2-Chloro-5-cyanophenylboronic acid, 98.0%, 250mg